HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tseng, Y.-L. Articles by Lai, W.-W. Search for Related Content PubMed PubMed Citation Articles by Tseng, Y.-L. Articles by Lai, W.-W.

Eur J Cardiothorac Surg 2000;18:666-670
© 2000 Elsevier Science NL

Intrathoracic muscle flap transposition in the treatment of fibrocavernous tuberculosis

Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, No 138, Sheng-Li Road, Tainan, Taiwan

Received 17 April 2000; received in revised form 18 August 2000; accepted 25 September 2000.

Corresponding author. Tel.: +886-6-2353-535 ext. 5187; fax: +886-6-2766-676
e-mail: tsengyl{at}mail.ncku.edu.tw

Background and objective: Conventionally, pulmonary resection with thoracoplasty is used to treat fibrocavernous complication of pulmonary tuberculosis. This operation is usually bloody, time-consuming with complicated postoperative course. To prevent massive blood loss and preserved pulmonary function, a more simplified operative procedure, cavernostomy combined intrathoracic muscle flap transposition was used and the outcome was evaluated in this study. Design: Retrospective review. Methodology: Between December 1989 and June 1996, a total of ten patients with fibrocavernous pulmonary tuberculosis were managed using cavernostomy combined with intrathoracic muscle flap transposition. Five of them had concomitant aspergilloma within the cavity while three had multiple drug resistant pulmonary tuberculosis. The muscle flap was used to plombage the cavity and reinforce the closure of bronchopleural fistula after cavernostomy. Results: Six postoperative complications occurred in five patients, including reformation of cavity (2), bronchopleurocutaneous fistulae (3), and postoperative bleeding (1). The success or failure of intrathoracic muscle flap transposition on patients with fibrocavernous tuberculosis was significantly correlated with the size of the cavity (194.0±11.2 vs. 283.0±44.6 cm³, P=0.016) and the number of bronchopleural fistulae (1.6±0.4 vs. 4.0±0.4, P=0.008). There was no operative death and in long term follow-up, there was no recurrence of hemoptysis or deterioration of pulmonary function in the successful group of patients. Conclusions: Cavernostomy combined with intrathoracic muscle flap transposition can be used to treat well-selected fibrocavernous pulmonary tuberculosis patients, except on patients with large size cavity, multiple bronchopleural fistulae or multiple drug resistance tuberculosis.

Key Words: Bronchopleural fistula • Intrathoracic muscle flap transposition • Tuberculosis

This article has been cited by other articles:

				R. Grima, A. Krassas, P. Bagan, A. Badia, F. Le Pimpec Barthes, and M. Riquet Treatment of complicated pulmonary aspergillomas with cavernostomy and muscle flap: interest of concomitant limited thoracoplasty Eur. J. Cardiothorac. Surg., November 1, 2009; 36(5): 910 - 913. [Abstract] [Full Text] [PDF]

				C. Rergkliang, A. Chetpaophan, V. Chittithavorn, and P. Vasinanukorn Surgical Management of Pulmonary Cavity Associated with Fungus Ball Asian Cardiovasc Thorac Ann, September 1, 2004; 12(3): 246 - 249. [Abstract] [Full Text] [PDF]

				M. B. Marshall, L. R. Kaiser, and J. C. Kucharczuk Simple technique for maximal thoracic muscle harvest Ann. Thorac. Surg., April 1, 2004; 77(4): 1465 - 1466. [Abstract] [Full Text] [PDF]